HETERO DRUGS LIMITED HETERO CORPORA

Hetero Drugs Limited, commonly known as Hetero, is one of India's largest privately held pharmaceutical companies and a prominent global producer of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Established in 1993, Hetero has evolved into a vertically integrated pharmaceutical organization with comprehensive capabilities in research and development, manufacturing, and marketing across diverse therapeutic areas. The company is recognized for its substantial contributions to global health, particularly through the production of affordable generic medicines for critical conditions such as HIV/AIDS, Hepatitis C, and various cancers. With a strong commitment to innovation, Hetero operates numerous state-of-the-art manufacturing facilities that adhere to rigorous international regulatory standards, catering to markets worldwide. Its broad product portfolio encompasses a wide array of therapeutic segments, including antivirals, oncology, neuroscience, cardiovascular, dermatology, and immunology.

Hetero Drugs Limited is a factory (manufacturer). It is an integrated pharmaceutical company that conducts extensive research and development, manufactures Active Pharmaceutical Ingredients (APIs) and finished dosage forms, and then markets these products globally.

Active Pharmaceutical Ingredients (APIs)

Finished Dosage Formulations

Biosimilars

Antiretrovirals for HIVAIDS

Oncology products

Cardiovascular drugs

Neurology drugs

Diabetes drugs

Hepatology drugs

Immunology drugs

Urology drugs

Respiratory drugs

Gastroenterology drugs

Pain management drugs

Anti-infective drugs